| Serial Number | 88912528 |
| Word Mark | SYN-NAT |
| Filing Date | Tuesday, May 12, 2020 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, June 4, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, April 2, 2024 |
| Description of Mark | The mark consists of designed letters "SYN-NAT". |
| Goods and Services | Tonics of medicines, namely, medicinal tea; Medicines for human purposes in the form of effervescent tablets, chewable tablet and chewing gum for use in preventing prostatitis, benign prostatic hyperplasia, urinary tract infection, gynecological inflammation, gastrointestinal disease; Medicines for human purposes in the form of effervescent tablets, chewable tablet and chewing gum for use in blood sugar regulation, liver protection, and as antioxidants, anti-hyperlipidemia, anti-aging, antineoplastic and antiviral agents for medical use; Medicines for human purposes, namely, medicines for the treatment of gastrointestinal disease, skin disease, cardiovascular disease, gout, asthma, nasitis, prostatic cancer, leukemia, melanoma, brain glioma, colon cancer, cervical cancer, thyroid cancer, kidney cancer, stomach cancer and lung cancer, hepatitis B, hepatitis C, AIDS and influenza, prostatitis, benign prostatic hyperplasia and gynecological inflammation, diabetes, sleep disorder and rheumatoid arthritis; Medicinal drinks; Capsules sold empty for pharmaceuticals; Pharmaceutical preparations for the treatment of gastrointestinal disease, skin disease, cardiovascular disease, gout, asthma, nasitis, prostatic cancer, leukemia, melanoma, brain glioma, colon cancer, cervical cancer, thyroid cancer, kidney cancer, stomach cancer and lung cancer, hepatitis B, hepatitis C, AIDS and influenza, prostatitis, benign prostatic hyperplasia and gynecological inflammation, diabetes, sleep disorder and rheumatoid arthritis; Chemico-pharmaceutical preparations for tumor-suppression and antiviral treatment; Troches, namely, tablets for use in tumor-suppression, as antivirals and for the treatment of chronic gastrointestinal disease; Tinctura in the nature of medicinal herb extracts; Herbs for medicinal purposes; Nutritional supplements; dietetic foods adapted for medical use, namely, dietetic drinks, dietetic crackers, dietetic sugar for medical use, dietetic sugar substitutes for medical use; Dietary and nutritional supplements; Dietary food supplements; Dietary supplemental drinks; Dietary supplements; Dietetic beverages adapted for medical use; Dietetic foods adapted for medical purposes; Dietetic foods and beverages adapted for medical use; Nutraceuticals for use as a dietary supplement; Nutritional supplements in the form of capsules, tablets, caplets, powder, syrups, gummies and gels; Sanitizing preparations for commercial use |
| Pseudo Mark | SYN NAT |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, May 26, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Medoncare Pharmaceutical Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Changsha, Hunan 410205 CN |
| Party Name | Medoncare Pharmaceutical Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Changsha, Hunan 410205 CN |
| Event Date | Event Description |
| Tuesday, May 26, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, May 15, 2020 | NEW APPLICATION ENTERED |
| Saturday, August 8, 2020 | ASSIGNED TO EXAMINER |
| Sunday, August 16, 2020 | NON-FINAL ACTION WRITTEN |
| Saturday, August 15, 2020 | SUSPENSION LETTER WRITTEN |
| Saturday, August 15, 2020 | LETTER OF SUSPENSION E-MAILED |
| Saturday, August 15, 2020 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Wednesday, February 17, 2021 | SUSPENSION LETTER WRITTEN |
| Sunday, August 16, 2020 | NON-FINAL ACTION E-MAILED |
| Sunday, August 16, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, January 26, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, January 26, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, January 26, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, February 16, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, February 16, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, February 17, 2021 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Wednesday, February 17, 2021 | LETTER OF SUSPENSION E-MAILED |
| Thursday, February 29, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 13, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 2, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 2, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 4, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, August 29, 2023 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Saturday, August 28, 2021 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Tuesday, March 1, 2022 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Thursday, September 1, 2022 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Tuesday, January 17, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, March 1, 2023 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |